CompoAtlas

Royal Jelly

Natural health product licensed in Canada

Other names
FIR AND MYRTLE Royal Jelly, Royal Jelly Powder
Licence holder
Nutrabalancecanada ltd.
NPN or DIN-HM
80075394
Status
Active licence
Licence date
1 February 2017
Revision date
Not provided
Form
Poudre
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Gelée royale

Source : Apis mellifera - sécrétion

500 GrammesNot calculated

Non-medicinal ingredients

Stéarate de magnésium, Glycérine, Maltodextrine, Collagène partiellement hydrolysé, Lippia citriodora flower water, Microcrystalline cellulose, Dioxyde de silicium

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 1 Cuillère à thé ; maximum: 3 Cuillère à théminimum: 1 Tous les jours ; maximum: 3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

A factor in the maintenance of good health; Helps the body to metabolize fats.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80075394

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line